Effectiveness of an Intervention (Effleurage and Petrissage) on severity of Chemotherapy Induced Peripheral Neuropathy (CIPN) among patients : a pilot randomized controlled trial

Rupinder Kaur, Reena Jairus, Meena Sudan

Abstract


Background: Chemotherapy Induced Peripheral Neuropathy (CIPN) is dose dependent nerve damaging adverse reaction with prevalence rate of 68.1% at the 1st month; 60.0 % at the 3rd month; and 30% at the 6th month of chemotherapy.

Objective:  to determine the effectiveness of an Intervention (Effleurage and Petrissage) on severity of CIPN among patients receiving chemotherapy

Methods: 60 patients either having third or fourth cycle of platinum based chemotherapy were subjected to quantitative approch. Random assignment were used among two groups with a pre- and post-test design. Interventional group received effleurage and petrissage prior to chemotherapy for a period of one month and comparison of CIPN level among both groups were done at 7th, 14th, 21st day & 1st month by using FACT/GOG-Ntx subscale.

Results: Pretest Mean+SD of CIPN in Intervention (17.17+4.907) and in Conventional care (17.10+ 4.421) group at t valve .055 and p value .956NS as measured by FACT/GOG-Ntx subscale. Posttest Mean+SD of CIPN in intervention (10.70±2.855) and conventional care (16.27±3.039) group after receiving effleurage and petrissage for one month at p value 0.000*.

Conclusions: Study concludes that Intervention (Effleurage and Petrissage) is effective, lucrative for decline in CIPN level among patients.

Key words: Effleurage, Petrissage, Chemotherapy, Induced, Peripheral, Neuropathy.

 


Full Text:

Remote PDF

References


Andersen, Hammond E., Pitz, M., & Steinfeld, K. (2020). An Exploratory Randomized Trial of Physical Therapy for the Treatment of Chemotherapy-Induced Peripheral Neuropathy. Neurorehabilitation and Neural Repair, 34 (3), 235–246

Betty, Neuman. (1996). The Neuman systems model in research and practice. NursSci, 9(2), 67-70

Diana, J, Wilkie., Janice, Kampbell., & Susan, Cutshall. et al (2000). Effects of Massage on Pain Intensity, Analgesics and Quality of Life in Patients with Cancer Pain: A Pilot Study of a Randomized Clinical Trial Conducted Within Hospice Care Delivery. The Hospice Journal, 15(3), 31-37

Duregon, F., Vendramin, B., & Bullo, V. (2018). Effect of exercise on cancer patients suffering chemotherapy-induced peripheral neuropathy undergoing treatment: A systematic review. Critical Review of Oncology Hematology, 121, 90–100

Hartmann, JT., & Lippot, HP. (2003). Toxicity of platinum compounds. Pharmacotherapy, 4(6), 889-901

Housley, SN., Nardelli, P., & Carrasco, DI. (2020). Cancer Exacerbates Chemotherapy-Induced Sensory Neuropathy. Cancer Research, 80(13), 2940–2955

Ian, R, Kleckner., Charles, Kamen., Jennifer, S, Gewandter., Nimish, A, Mohile., Eva, Culakova., Jeffrey, Giguere., Pavan, S, Reddy. (2018). Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer, 26(4), 1019-1028. https://doi: 10.1007/s00520-017-4013-0.

Joan, Elizabeth, Cunningham., Teresa, Kelechi., & Katherine, Sterba.(2011). Case report of a patient with chemotherapy-induced peripheral neuropathy treated with manual therapy (massage). Support Care Cancer, Sep;19(9):1473-6. https:// doi: 10.1007/s00520-011-1231-8. Epub 2011 Jul 16

Kaley, TJ., & DeAngelis, LM. (2019) Therapy of chemotherapy induced peripheral neuropathy. Br J Haematology ,145, 3–14

Manish, R, Sharma., Shailly, Mehrotra., & Elizabeth, Gray. (2020). Personalized Management of Chemotherapy-Induced Peripheral Neuropathy Based on a Patient Reported Outcome: CALGB 40502 (Alliance). J Clin Pharmacol, 60(4), 444-452

Marianne, Ewertz., Camilla, Qvortrup., & LiseEckhoff. (2015). Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives. Actaoncologica, 54(5), 587-591

Marmiroli, P., & Cavaletti G. (2010). Chemotherapy-induced peripheral neurotoxicity. Nat Rev Neurol, 6, 657-666

Marta, Seretny. , Gillian, L Currie., & Emily S Sena. (2014). Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain, 155(12), 2461-2470

McDonald, ES., & Windebank, AJ. (2002). Cisplatin-Induced Apoptosis of DRG Neurons Involves Bax Redistribution and Cytochrome release but not fast Receptor Signaling. Neurobiology of disease, 9(2), 220-233

Miltenburg, NC., & Boogerd W. (2014). Chemotherapy-induced neuropathy: a comprehensive survey. Cancer treatment reviews, 40(7), 872-882

Mols, F., Van, Poll-Franse, L.V., & Vreugdenhil, G. (2016). Reference data of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Questionnaire in the general Dutch population. Eur. J. Cancer, 69, 28–38

Post, White, J., Fitzgerald, M., & Savik, K. (2015). Massage therapy for children with cancer. J Pediatrics Oncology Nurse, 26(11), 16-28

Sutton, G., Brunetto, VL., & Kilgore, L. (2000). A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: a Gynecologic Oncology Group Study. Gynecologic oncology , 79(2), 147-153

Staff ,NP., Grisold, A., & Grisold, W. (2017). Chemotherapy-induced peripheral neuropathy: A current review. Annals of Neurology, 81(6), 772–781

Valtonen, EJ., & Lilius, HG. (2013). Syncardial massage in diabetic and other neuropathies lower extremities. Disease Nervous System, 34(3), 192–194

Von, Hehn, CA., Baron, R., & Woolf ,CJ. (2012). Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron, 73, 638-652

Woolf , CJ., & Mannion, RJ. (1999). Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet, 353, 1959-1964

Zajaczkowska, R., & Kocot, Kępska M. (2019). Mechanisms of Chemotherapy-Induced Peripheral Neuropathy. International Journal of Molecular Sciences, 20 (6), 1451-1452


Refbacks

  • There are currently no refbacks.


Bookmark and Share